Resistant type II cryoglobulinaemic vasculitis successfully treated with bortezomib in a patient with SLE. (2019)
Attributed to:
MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bcr-2018-226083
PubMed Identifier: 30612104
Publication URI: http://europepmc.org/abstract/MED/30612104
Type: Journal Article/Review
Volume: 12
Parent Publication: BMJ case reports
Issue: 1
ISSN: 1757-790X